Cargando…

Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)

BACKGROUND: One of the usual problems psychologists and clinicians face in clinical practice is differential diagnostics of Alzheimer’s disease and depression. It has been reported that the ACE and ACE-R could discriminate the cognitive dysfunctions due to depression from that due to dementia, altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotomskis, Augustinas, Margevičiūtė, Ramunė, Germanavičius, Arūnas, Kaubrys, Gintaras, Budrys, Valmantas, Bagdonas, Albinas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415229/
https://www.ncbi.nlm.nih.gov/pubmed/25924912
http://dx.doi.org/10.1186/s12883-015-0315-3
_version_ 1782369037685096448
author Rotomskis, Augustinas
Margevičiūtė, Ramunė
Germanavičius, Arūnas
Kaubrys, Gintaras
Budrys, Valmantas
Bagdonas, Albinas
author_facet Rotomskis, Augustinas
Margevičiūtė, Ramunė
Germanavičius, Arūnas
Kaubrys, Gintaras
Budrys, Valmantas
Bagdonas, Albinas
author_sort Rotomskis, Augustinas
collection PubMed
description BACKGROUND: One of the usual problems psychologists and clinicians face in clinical practice is differential diagnostics of Alzheimer’s disease and depression. It has been reported that the ACE and ACE-R could discriminate the cognitive dysfunctions due to depression from that due to dementia, although this is not uniform in all studies. The current study aimed to evaluate the utility of the ACE-R to differentiate late-life onset depression (with severe episode) from mild-moderate Alzheimer’s Disease (AD). METHODS: This study received approval from the Lithuanian Bioethics Committee. All participants were older than 50 years (mean age = 66.52 (±8.76) years). The study sample consisted of 295 individuals: 117 with severe depression, 85 with mild-moderate Alzheimer’s disease (AD), and 94 age, gender and education matched participants of control group. RESULTS: The ACE-R had high sensitivity (100%) and specificity (81%) at detecting cognitive impairments related to AD. Patients with late-life onset depression (ACE-R mean 76.82, SD = 7.36) performed worse than controls (ACE-R mean 85.08, SD = 7.2), but better than the AD group (ACE-R mean 54.74, SD = 12.19). Participants with late-life onset depression were differentiated by mild impairment in the ACE-R total score with mild memory (13.79, SD = 6.29) and greater deficits in letter fluency (3.65, SD = 1.21) than in semantic fluency (4.68, SD = 1.23). Participants with AD were differentiated by severely impaired performance on attention and orientation (11.80, SD = 2.93), memory (8.25, SD = 3.47) and language subtests (17.21, SD = 4.04), and moderately impaired performance on verbal fluency (6.07, SD = 2.74). CONCLUSIONS: ACE-R has diagnostic accuracy in detecting people with AD and can be used in differential diagnostics of late-life onset depression (severe episode) and AD. Diagnostic accuracy may be improved by analyzing the neuropsychological profiles and using lower cutoffs for different age groups.
format Online
Article
Text
id pubmed-4415229
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44152292015-05-01 Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R) Rotomskis, Augustinas Margevičiūtė, Ramunė Germanavičius, Arūnas Kaubrys, Gintaras Budrys, Valmantas Bagdonas, Albinas BMC Neurol Research Article BACKGROUND: One of the usual problems psychologists and clinicians face in clinical practice is differential diagnostics of Alzheimer’s disease and depression. It has been reported that the ACE and ACE-R could discriminate the cognitive dysfunctions due to depression from that due to dementia, although this is not uniform in all studies. The current study aimed to evaluate the utility of the ACE-R to differentiate late-life onset depression (with severe episode) from mild-moderate Alzheimer’s Disease (AD). METHODS: This study received approval from the Lithuanian Bioethics Committee. All participants were older than 50 years (mean age = 66.52 (±8.76) years). The study sample consisted of 295 individuals: 117 with severe depression, 85 with mild-moderate Alzheimer’s disease (AD), and 94 age, gender and education matched participants of control group. RESULTS: The ACE-R had high sensitivity (100%) and specificity (81%) at detecting cognitive impairments related to AD. Patients with late-life onset depression (ACE-R mean 76.82, SD = 7.36) performed worse than controls (ACE-R mean 85.08, SD = 7.2), but better than the AD group (ACE-R mean 54.74, SD = 12.19). Participants with late-life onset depression were differentiated by mild impairment in the ACE-R total score with mild memory (13.79, SD = 6.29) and greater deficits in letter fluency (3.65, SD = 1.21) than in semantic fluency (4.68, SD = 1.23). Participants with AD were differentiated by severely impaired performance on attention and orientation (11.80, SD = 2.93), memory (8.25, SD = 3.47) and language subtests (17.21, SD = 4.04), and moderately impaired performance on verbal fluency (6.07, SD = 2.74). CONCLUSIONS: ACE-R has diagnostic accuracy in detecting people with AD and can be used in differential diagnostics of late-life onset depression (severe episode) and AD. Diagnostic accuracy may be improved by analyzing the neuropsychological profiles and using lower cutoffs for different age groups. BioMed Central 2015-04-17 /pmc/articles/PMC4415229/ /pubmed/25924912 http://dx.doi.org/10.1186/s12883-015-0315-3 Text en © Rotomskis et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rotomskis, Augustinas
Margevičiūtė, Ramunė
Germanavičius, Arūnas
Kaubrys, Gintaras
Budrys, Valmantas
Bagdonas, Albinas
Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title_full Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title_fullStr Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title_full_unstemmed Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title_short Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
title_sort differential diagnosis of depression and alzheimer’s disease with the addenbrooke's cognitive examination-revised (ace-r)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415229/
https://www.ncbi.nlm.nih.gov/pubmed/25924912
http://dx.doi.org/10.1186/s12883-015-0315-3
work_keys_str_mv AT rotomskisaugustinas differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer
AT margeviciuteramune differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer
AT germanaviciusarunas differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer
AT kaubrysgintaras differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer
AT budrysvalmantas differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer
AT bagdonasalbinas differentialdiagnosisofdepressionandalzheimersdiseasewiththeaddenbrookescognitiveexaminationrevisedacer